Furthermore, using a systemic-portal insulin infusion method, Bergman et al. [104,105] have hypothesized that reduced hepatic insulin clearance can lead not only to hyperinsulinemia and insulin resistance, but also to increased risk of type 2 diabetes. This evidence concerns the gene INS and Insulin resistance.